FDA clears IRadimed's MRI-compatible patient monitor

The U.S. Food and Drug Administration (FDA) has cleared MRI accessories developer IRadimed's MRI-compatible patient vital signs monitoring system.

IRadimed 3880 features a wireless tablet remote control that communicates vital signs information to clinicians as patients are transported from critical care departments to the MRI scanner room, according to the firm. It tracks patients' electrocardiogram (ECG), SpO₂, respiratory CO₂, blood pressure, and temperature data, and is rated for use in magnetic fields up to 30,000 gauss, IRadimed said.